FGF21信号在肺纤维化中发挥抗纤维化作用
该研究探讨FGF21在肺纤维化中的作用。IPF患者血浆FGF21升高而KLB降低;Fgf21缺陷小鼠对博来霉素更敏感;PEG化FGF21可减轻肺纤维化;体外FGF21联合KLB抑制小鼠肺上皮细胞凋亡。结论提示FGF21可能通过抑制肺泡2型细胞凋亡发挥抗纤维化作用。
要点
- IPF患者血浆FGF21升高、KLB降低。
- Fgf21缺陷小鼠对博来霉素诱导肺纤维化更敏感。
- PEG化FGF21可减轻博来霉素诱导的小鼠肺纤维化。
核心结论
- FGF21在肺纤维化中可能通过抑制肺泡2型细胞凋亡发挥抗纤维化作用。
研究设计与样本
- 评估IPF患者与对照者血浆FGF21和KLB浓度。
- 比较Fgf21缺陷小鼠与野生型同窝小鼠在博来霉素气管内注射后第14天肺纤维化程度。
- 博来霉素后第7、10、14、17天重复皮下注射PEG化FGF21类似物,第21天处死小鼠评估肺纤维化。
- 体外评估FGF21单用或联合KLB对小鼠肺上皮15细胞凋亡及人肺成纤维细胞表型的影响。
主要发现
- IPF患者血浆中FGF21浓度升高,而KLB浓度降低。
- 与野生型同窝小鼠相比,Fgf21缺陷小鼠对博来霉素的敏感性增加。
- 与接受稀释剂的对照组相比,PEG化FGF21治疗减轻肺纤维化,表现为损伤评分降低、纤维化标志物和促纤维化介质表达减少。
- 在小鼠肺上皮15细胞中,FGF21联合KLB刺激通过降低BAX和BIM抑制凋亡。
- 成纤维细胞表型未改变。
临床怎么用
- FGF21信号通路可能成为肺纤维化的潜在治疗靶点。
- FGF21的抗纤维化作用可能主要通过抑制肺泡2型细胞凋亡实现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Idiopathic pulmonary fibrosis (IPF) is a lethal disease with limited therapeutic options. FGF21 (fibroblast growth factor 21), an endocrine fibroblast growth factor that acts through the FGFR1 (fibroblast growth factor receptor 1)/KLB (β-Klotho) pathway, mitigates liver fibrosis. Objectives: We hypothesized that FGF21 could exert antifibrotic properties in the lung. Methods: The concentrations of FGF21 and KLB in the plasma of patients with IPF and control subjects were assessed. Pulmonary fibrosis development was assessed in Fgf21-deficient mice compared with wild-type littermates, at Day 14 (D14) after the intratracheal injection of bleomycin. We determined the effect of repeated subcutaneous injections of a PEGylated FGF21 analog at D7, D10, D14, and D17 after bleomycin on the development of pulmonary fibrosis. Mice were killed at D21. The effects of FGF21, alone or with KLB, on apoptosis in murine lung epithelial 15 cells and on the phenotype of human lung fibroblasts were assessed in vitro. Measurements and Main Results: In the plasma of patients with IPF, FGF21 concentrations were increased, while KLB concentrations were decreased. Fgf21-deficient mice showed increased sensitivity to bleomycin in comparison with their wild-type littermates. Treatment with PEGylated FGF21 mitigated lung fibrogenesis, as evidenced by a lower injury score and decreased fibrosis markers and profibrotic mediator expression compared with the control group receiving the diluent. In murine lung epithelial 15 cells, stimulation with FGF21 and KLB inhibited apoptosis, through the decrease of BAX and BIM. Fibroblastic phenotype remained unaltered. Conclusions: Our data indicate a possible antifibrotic effect of FGF21 in the lung achieved through the inhibition of alveolar type 2 cell apoptosis.
引用
- Ghanem M, Archer G, Justet A, et al. FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis. Am J Respir Crit Care Med. 2025. PMID: 39637324. doi:10.1164/rccm.202311-2021OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。